$B9V1i(B $B;~9o(B | $B9V1i(B $BHV9f(B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $BJ,N`(B $BHV9f(B | $B$BHV9f(B | |
$BIt2q%7%s%]%8%&%`(B SY-14. <$B8GAj$NIJ=@O5;=Q$K4X$9$k%7%s%]%8%&%`!J:`NA!&3&LLIt2q!K(B> $B$3$N%7%s%]%8%&%`$N9V1i;~4V$O(B $BH/I=#1#2J,!\F$O@#8J,(B $B$G$9!#(B |
(9:00$B!A(B10:40) ($B:BD9(B $BA0ED(B $B8w<#(B) |
9:00$B!A(B 9:20 | F101 | $B%7%_%e%l!<%7%g%s$K$h$kM-5!J*7k>=$N3K2=!&@.D9B.EY%Q%i%a!<%?;;=P(B
($BAaBgM}9)(B) ($B3X(B)$B!{G_ED(B $BN4B@(B$B!&(B ($B3X(B)$BIJED(B $B>042(B$B!&(B ($B@5(B)$BJ?Bt(B $B@t(B | nucleation rate growth rate simulation
| SY-14 | 597 |
9:20$B!A(B 9:40 | F102 | $B?e;@2=%9%H%m%s%A%&%`(B8$B?e1v7k>=$rE:2C$7$?1v2=%+%k%7%&%`(B6$B?e1vM;1U$N2aNd5Q29EY$K5Z$\$9r7o$N1F6A(B
($BAaBgM}9)8&(B) ($B@5(B)$BEOn5(B $BM5G7(B | Nucleation Melt Heat Storage
| SY-14 | 22 |
9:40$B!A(B 10:00 | F103 | N2$B%U%!%$%s%P%V%k$HIOMOG^$NJ;MQ$K$h$k%0%j%7%s$N>=@O8=>](B -$BIOMOG^$N=B?7A$K5Z$\$91F6A(B-
($BF|Bg@8;:9)(B) ($B3X(B·$B5;4p(B)$B!{A0_7(B $B>MB@(B$B!&(B ($B@5(B)$B:4F#(B $BIR9,(B$B!&(B ($B@5(B)$B2,ED(B $B>;$B!&(B ($B@5(B)$BF|=)(B $B=SI'(B$B!&(B ($B@5(B)$B>>K\(B $B??OB(B | glycine antisolvent crystallization fine-bubbles
| SY-14 | 869 |
10:00$B!A(B 10:20 | F104 | ASP3026$B$N7k>=B?7A@)8f@oN,$H%$%s%i%$%s%i%^%sJ,8wK!$rMQ$$$?MO1U9=B$%b%K%?%j%s%0(B
($B%"%9%F%i%9@=Lt(B) ($BK!(B)$B!{C]8}(B $BOB9((B$B!&(B ($BK!(B)$B>.]$(B $BOB5A(B$B!&(B ($BK!(B)$BJ?_7(B $B=S(B$B!&(B ($BK!(B)$B?%0f(B $BN<5#(B$B!&(B ($BK!(B)$B2,ED(B $BL-(B$B!&(B ($B%"%9%F%i%9%U%!!<%^%F%C%/(B) ($BK!(B)$B2HED(B $B@.(B$B!&(B ($BG@9)Bg(B) ($B@5(B)$BBl;3(B $BGn;V(B | Polymorph Raman
| SY-14 | 19 |
10:20$B!A(B 10:40 | F105 | $B=E:2C$K$h$k%5%V%_%/%m%s%*!<%@!<$K$*$1$k(BPt$BN3;R$NN37B@)8f(B
($BAaBg(B) ($B3X(B)$B!{0KCNCO(B $B??@!(B$B!&(B ($B3X(B)$B=)MU(B $B9I;R(B$B!&(B ($B3X(B)$BD9Hx(B $B1Q;V(B$B!&(B ($B@5(B)$BJ?Bt(B $B@t(B | Reaction Crystallization Size Control Pt Particle
| SY-14 | 712 |
(10:40$B!A(B12:00) ($B:BD9(B $BA%1[(B $BK.IW(B) |
10:40$B!A(B 11:00 | F106 | $B4T85>=@O$K$*$1$k(BpH$B$K$h$k(BAu$BN3;R$NN37B@)8f$*$h$SN3;R@.D95!9=$N2rL@(B
($BAaBg1!M}9)(B) ($B3X(B)$B!{=)MU(B $B9I;R(B$B!&(B ($B3X(B)$B0KCNCO(B $B??@!(B$B!&(B ($BAaBgM}9)(B) ($B@5(B)$BJ?Bt(B $B@t(B | reaction crystallization pH sub-micron Au particle
| SY-14 | 947 |
11:00$B!A(B 11:20 | F107 | $B7Z>F(Bdolomite$B7|By1U$NC:;@2=H?1~$K$h$k(BMg$BC:;@1v$N>=@O$HJ,N%(B
($B85ElKLBg1!4D(B) ($B3X(B)$B2,ED(B $B2BM4(B$B!&(B ($BElKLBg1!4D(B) ($B3X(B)$B!{9b66(B $BCRH~(B$B!&(B ($B@5(B)$BEDCf(B $B9(0l(B$B!&(B ($BElKLBg1!9)(B) ($B@5(B)$BEOn5(B $B8-(B$B!&(B ($BElKLBg1!4D(B) ($B@5(B)$BAjED(B $BBn(B$B!&(B ($B@5(B)$B%9%_%9(B $B%j%A%c!<%I(B | dolomite carbonation magnesium carbonate
| SY-14 | 786 |
11:20$B!A(B 11:40 | F108 | $BH?1~>=@OK!$K$h$kC:;@1vHy7k>=$NIJ
($BAaBg@h?JM}9)(B) ($B@5(B)$B!{J?Bt(B $B@t(B$B!&(B ($B3X(B)$B@>B<(B $B5f(B$B!&(B ($B3X(B)$B1`It(B $BM4;R(B$B!&(B ($B3X(B)$BLJB<(B $B9@?M(B | $BH?1~>=@O(B $BC:;@1vHyN3;R(B $BIJ | SY-14 | 133 |
11:40$B!A(B 12:00 | F109 | $B%I%i%`%U%l!<%+$rMQ$$$?6&>=E`7k>=@OK!$K$h$k(B(NH4)2SO4-Na2SO4-H2O$B7O$+$i$NG;=LN20B1U2s<}$NJ,N%FC@-$=$NB>$K$D$$$F(B
($B%+%D%i%.9)6H(B) ($BK!(B)$B!{5HED(B $BM55,(B$B!&(B ($BK!(B)$BOPED(B $B>09((B$B!&(B ($B@5(B)$B;0LZ(B $B=(M:(B$B!&(B ($BJ<8K8)Bg9)(B) ($B@5(B)$BA0ED(B $B8w<#(B | Drum flaker Eutectic point freezing concentration
| SY-14 | 433 |
(13:00$B!A(B14:20) ($B:BD9(B $BEgFb(B $B |
13:00$B!A(B 13:20 | F113 | $B;iKC;@$NM;1U>=@O$K$*$1$kMO
($BJ<8K8)Bg9)(B) ($B3X(B)$B!{F#@n(B $BBv?M(B$B!&(B ($B@5(B)$B;3K\(B $BBs;J(B$B!&(B ($B@5(B)$BA0ED(B $B8w<#(B$B!&(B ($B@5(B)$BJ!0f(B $B7<2p(B$B!&(B ($B9q4D8&(B) ($B@5(B)$BAR;}(B $B=(IR(B | melt crystallization effective distribution coefficient solute distribution theory
| SY-14 | 171 |
13:20$B!A(B 13:40 | F114 | Cr($B-7(B)$BB8:_2<$G$NN2;@%+%j%&%`7k>=$NMO2r$K$*$1$k3F7k>=LL$NI=LL2r@O(B
($BNk9b@l(B) ($B@5(B)$B!{A%1[(B $BK.IW(B$B!&(B $B:,4_(B $BN$F`(B | Dissolution Behavior Additives Energy Dispersive X-ray Spectrometry
| SY-14 | 538 |
13:40$B!A(B 14:00 | F115 | $B9b05NO2<$G$NL5EE2r%K%C%1%k!>%j%s$a$C$-$K4X$9$k
($BJ<8K8)Bg9)(B) ($B3X(B)$B!{?.5H(B $BM5B@(B$B!&(B ($B@5(B)$B;3K\(B $BBs;J(B$B!&(B ($B@5(B)$BA0ED(B $B8w<#(B$B!&(B ($B6&(B)$BJ!<<(B $BD>$B!&(B ($B6&(B)$BH,=E(B $B??<#(B$B!&(B ($B@5(B)$BJ!0f(B $B7<2p(B | electroless plating high pressure hydrogen
| SY-14 | 172 |
14:00$B!A(B 14:20 | F116 | $B;0;@2=%b%j%V%G%s?eOBJ*E:2C$K$h$k(BZMH$B7k>=$NJILLIUCeM^@)(B
($BAaBgM}9)(B) ($B3X(B)$B!{0KF#(B $BBgM:(B$B!&(B ($B@5(B)$BJ?Bt(B $B@t(B | Nuclear fuel reprocessing Zirconium molybdate hydrate Nucleation
| SY-14 | 675 |
(14:20$B!A(B15:40) ($B:BD9(B $BCfB<(B $B0lJf(B) |
14:20$B!A(B 14:40 | F117 | $B%*%$%j%s%0%"%&%H$r7PM3$9$k7k>=2=8=>]$NB?@.J,Aj?^$rMQ$$$?2r@O(B
($BG@9)Bg1!9)(B) ($B3X(B)$B!{1|=P(B $BMu(B$B!&(B ($B@5(B)$B9)F#(B $BfF;|(B$B!&(B ($B@5(B)$BBl;3(B $BGn;V(B | Crystallization Oiling-out phenomena Phase diagram
| SY-14 | 176 |
14:40$B!A(B 15:00 | F118 | $B%*%$%k2=$r2p$7$?%0%k%?%A%*%s%J%H%j%&%`7k>=$N>=@O(B
($B:e;TBg1!9)(B) ($B@5(B)$B!{8^==Mr(B $B9,0l(B$B!&(B $BNkLZ(B $BM:Bg(B$B!&(B ($B6(OBH/9Z%P%$%*(B) ($BIt(B)$BD9Ln(B $B9((B$B!&(B ($B:e;TBg1!9)(B) ($B@5(B)$BBgEh(B $B42(B | crystallization solvate amorphous
| SY-14 | 582 |
15:00$B!A(B 15:20 | F119 | $B@EEEE*Aj8_:nMQ$r6nF0NO$H$7$?%9%H%l%W%H%"%S%8%s$N7k>=2=(B
($BElBg1!9)(B) ($B@5(B)$B!{FnH*(B $B9'2p(B$B!&(B ($B3X(B)$B;0IJ(B $B6)1{(B$B!&(B ($B86;RNO5!9=!&NL;R%S!<%`(B) $B0BC#(B $B4pBY(B$B!&(B $B@6?e(B $BN\H~(B$B!&(B $B9uLZ(B $BNIB@(B$B!&(B ($BElBg1!9)(B) ($B@5(B)$BD9Eo(B $B519T(B | Electrostatic interaction Crystallization Streptavidin
| SY-14 | 512 |
15:20$B!A(B 15:40 | F120 | $B0[Aj3&LL$r>=@O>l$H$7$?7k>=N3;R72$N@.D98=>]$N4Q;!$H$=$NI>2A(B
($BG@9)Bg1!9)(B) ($B3X(B)$B!{NkLZ(B $B=U9a(B$B!&(B ($B@5(B)$B9)F#(B $BfF;|(B$B!&(B ($B@5(B)$BBl;3(B $BGn;V(B | Crystallization Templated crystallization Different Phase Interface
| SY-14 | 178 |
(15:40$B!A(B17:20) ($B:BD9(B $B8^==Mr(B $B9,0l(B) |
15:40$B!A(B 16:00 | F121 | $B%"%_%m%$%I@-%?%s%Q%/
($B2,;3Bg1!4D@8(B) ($B@5(B)$B!{EgFb(B $B$B!&(B ($B3X(B)$B4dB<(B $BH~$B!&(B ($B@5(B)$BLZB<(B $B9,7I(B | Amyloid Nucleation Bio-interface
| SY-14 | 933 |
16:00$B!A(B 16:20 | F122 | $BDKIw$K$*$1$kG";@@O=P$KM?$($k29EY$N1F6A(B
($BAaBgM}9)(B) ($B3X(B·$B5;4p(B)$B!{Bg;3(B $BGn;K(B$B!&(B ($B@5(B)$B>.KY(B $B?<(B$B!&(B ($B@5(B)$BJ?Bt(B $B@t(B | crystallization uric acid gout
| SY-14 | 813 |
16:20$B!A(B 16:40 | F123 | $B5U?;F)Kl$K$h$kMO=@8@.(B
($B2#9qBg9)(B) ($B@5(B)$B!{CfB<(B $B0lJf(B$B!&(B $BIz8+(B $B$"$:$5(B | Reverse Osmosis Crystallization Concentration Polarization
| SY-14 | 558 |
16:40$B!A(B 17:00 | F124 | $B%7%/%m%G%-%9%H%j%s7O6bB0M-5!9=B$BN$X$NK'9aB2%+%k%\%s;@$N5[Ce(B
($B?rBg9)(B) ($B3X(B)$B!{F;ED(B $B9R(B$B!&(B ($B3X(B)$B1J0f(B $B0IF`(B$B!&(B ($B@5(B)$B]/LZ(B $BH~:Z(B$B!&(B ($B@5(B)$B@>ED(B $B@5;V(B$B!&(B ($B@5(B)$BApJI(B $B9n8J(B | Adsorption Carboxylic acid Cyclodextrin
| SY-14 | 116 |
17:00$B!A(B 17:20 | F125 | $B%(%T%,%m%+%F%-%s%,%l!<%H$N%7%/%m%G%-%9%H%j%sJq@\2=9gJ*$N7k>=@.D9B.EY$N2r@O(B
($BJ!;3Bg@8L?9)(B) ($B@5(B)$B;3K\(B $B1QFs(B$B!&(B ($B@5(B)$B!{Cf:j(B $B@i?R(B$B!&(B ($BJ!;3BgLt(B) $BC]ED(B $B:;5-(B$B!&(B ($BJ!;3Bg@8L?9)(B) $B|bED(B $BM}$B!&(B $B2<;J(B $BBg5.(B | Clathrate Crystallization Cyclodextrin
| SY-14 | 781 |